B. Riley analyst Kyle Bauser lowered the firm’s price target on Performant Financial (PFMT) to $7 from $8 and keeps a Buy rating on the shares post the Q3 report. The company reiterated fiscal 2024 healthcare sales and adjusted EBITDA guidance while reducing nonhealthcare sales expectations, the analyst tells investors in a research note.